J
Juan M. Mejia-Vilet
Researcher at National Autonomous University of Mexico
Publications - 52
Citations - 1410
Juan M. Mejia-Vilet is an academic researcher from National Autonomous University of Mexico. The author has contributed to research in topics: Lupus nephritis & Medicine. The author has an hindex of 12, co-authored 36 publications receiving 421 citations.
Papers
More filters
Journal ArticleDOI
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Brad H. Rovin,Sharon G. Adler,Jonathan Barratt,Frank Bridoux,Kelly A. Burdge,Tak Mao Chan,H. Terence Cook,Fernando C. Fervenza,Keisha L. Gibson,Richard J. Glassock,David Jayne,Vivekanand Jha,Adrian Liew,Zhihong Liu,Juan M. Mejia-Vilet,Carla M. Nester,Jai Radhakrishnan,Elizabeth M. Rave,Heather N. Reich,Pierre Ronco,Jan-Stephan F. Sanders,Sanjeev Sethi,Yusuke Suzuki,Sydney C.W. Tang,Vladimir Tesar,Marina Vivarelli,Jack F.M. Wetzels,Jürgen Floege +27 more
Journal ArticleDOI
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases.
Brad H. Rovin,Sharon G. Adler,Jonathan Barratt,Frank Bridoux,Kelly A. Burdge,Tak Mao Chan,H. Terence Cook,Fernando C. Fervenza,Keisha L. Gibson,Richard J. Glassock,David Jayne,Vivekanand Jha,Adrian Liew,Zhihong Liu,Juan M. Mejia-Vilet,Carla M. Nester,Jai Radhakrishnan,Elizabeth M. Rave,Heather N. Reich,Pierre Ronco,Jan-Stephan F. Sanders,Sanjeev Sethi,Yusuke Suzuki,Sydney C.W. Tang,Vladimir Tesar,Marina Vivarelli,Jack F.M. Wetzels,Lyubov Lytvyn,Jonathan C. Craig,David J. Tunnicliffe,Martin Howell,Marcello Tonelli,Michael Cheung,Amy Earley,Jürgen Floege +34 more
TL;DR: The Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Management of Glomerular Diseases is an update to the KDIGO 2012 guideline.
Journal ArticleDOI
Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone
Juan M. Mejia-Vilet,Victoria Ramírez,Cristino Cruz,Norma Uribe,Gerardo Gamba,Norma A. Bobadilla +5 more
TL;DR: Spironolactone administration prevents the renal injury induced by I/R, suggesting that aldosterone plays a central role in this model of renal injury.
Journal ArticleDOI
Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement.
Bertha M Córdova-Sánchez,Juan M. Mejia-Vilet,Luis E. Morales-Buenrostro,Georgina Loyola-Rodríguez,Norma O. Uribe-Uribe,Ricardo Correa-Rotter +5 more
TL;DR: Serological classification adequately delimited 24-month glomerular filtration rate (eGFR) evolution, but it did not predict renal nor patient survival, and histopathological classification predicted response to therapy.
Journal ArticleDOI
Urinary Soluble CD163: a Novel Noninvasive Biomarker of Activity for Lupus Nephritis.
Juan M. Mejia-Vilet,Xiaolan L Zhang,Cristino Cruz,Mayra L Cano-Verduzco,John P. Shapiro,Haikady N. Nagaraja,Luis E. Morales-Buenrostro,Brad H. Rovin +7 more
TL;DR: Evaluation of urinary CD163 in patients with persistent proteinuria at 6 months improved the prediction of who would achieve complete renal response at 12 months and is a promising activity biomarker that varies over time with lupus nephritis activity and treatment.